Summary & Overview
CPT 88741: Transcutaneous Quantitative Methemoglobin Measurement
CPT code 88741 represents a quantitative transcutaneous procedure to evaluate methemoglobin levels through the skin. This noninvasive monitoring test has clinical relevance for detecting and managing methemoglobinemia, a condition that can impair oxygen delivery and may be encountered in emergency, inpatient, and outpatient settings. Nationally, standardized reporting and correct use of this code support clinical tracking, billing consistency, and appropriate utilization of noninvasive hemoglobin variant testing.
Key payers covered in this publication include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for transcutaneous methemoglobin measurement, guidance on typical sites of service, and operational notes such as the one-per-day reporting limitation. The report summarizes common modifiers and payer patterns where available and highlights implications for coding accuracy and claims processing. Where specific payer policy details, taxonomies, or diagnosis mappings are not provided in the input, the publication notes that those data elements are not available.
This piece is intended for coding professionals, clinical laboratory managers, and revenue cycle staff seeking a concise, national-level reference on CPT code 88741, its clinical purpose, and the key administrative considerations for documentation and daily reporting.
Billing Code Overview
CPT code 88741 describes a quantitative transcutaneous measurement of methemoglobin, performed by an analyst. The procedure evaluates methemoglobin levels through the skin using noninvasive transcutaneous technology. Report this code only once per day.
-
Service type: Noninvasive transcutaneous quantitative laboratory/monitoring procedure
-
Typical site of service: Outpatient clinic, emergency department, inpatient bedside monitoring, or other clinical settings where noninvasive hemoglobin variant monitoring is performed
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an emergency department or urgent care with symptoms suggestive of oxidant-induced hemoglobin dysfunction — for example, cyanosis unresponsive to oxygen therapy, chocolate-brown colored blood, shortness of breath, tachycardia, or altered mental status after exposure to topical or systemic oxidizing agents (dapsone, local anesthetics such as benzocaine, nitrites, or smoke inhalation). A clinician orders a quantitative transcutaneous methemoglobin measurement to rapidly assess percent methemoglobin noninvasively.
Workflow: On presentation, triage identifies hypoxemia not corrected by supplemental oxygen and clinical concern for methemoglobinemia. The clinician documents the indication and orders the test. A trained technologist or analyzer operator places the transcutaneous sensor on the patient’s finger or earlobe and runs the 88741 measurement. The analyzer displays a quantitative percent methemoglobin value and documents the result in the medical record. If elevated, the care team uses the result along with clinical assessment to determine need for antidotal therapy (e.g., methylene blue) and further laboratory confirmation if indicated. The code 88741 is billed once per day for the transcutaneous quantitative methemoglobin procedure.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 |